Navigation Links
CHPA Statement on Statewide Indiana Consumer Poll
Date:3/4/2013

WASHINGTON, March 4, 2013 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement today on a recent poll of Indiana voters conducted by The Polling Company and supported by CHPA. The poll, which surveyed 607 Hoosiers on February 4-6th, found that a 65 percent majority of Hoosiers opposed changing state law to require a doctor's prescription for cold and allergy medicines containing the decongestant pseudoephedrine (PSE).  The poll also found that 84 percent of respondents report they use PSE-containing medicines to treat common symptoms.

"The new Indiana survey is very important because in recent months, well-intentioned lawmakers have proposed legislation that would make it difficult for law-abiding Hoosiers to access the nonprescription medicines they know and trust," said Carlos Gutierrez , senior director of state government affairs for CHPA. "Clearly these proposals do not have the support of Indiana voters, many of whom sufferer from frequent cold and allergy symptoms. While we support efforts to combat the illegal sales of pseudoephedrine, lawmakers should advance solutions that target criminals, not honest citizens. To that end, CHPA is doing everything possible to help Senator Carlin Yoder garner support for his commonsense anti-meth bill, SB 496. Senator Yoder's bill would enhance the state's electronic PSE tracking system, implement stiffer penalties for meth-related crime, and apply sensible PSE purchasing limits."

Key findings from the poll:  

  • 84% of Hoosiers report they rely on the over-the-counter medicines containing pseudoephedrine that would be impacted by changing the law to require a doctor's prescription.
  • A 65%-majority of Hoosiers opposed changing the law to require a doctor's prescription for the purchase of cold and allergy medicines containing pseudoephedrine.  This total included 52% that STRONGLY opposed new rules for pseudoephedrine medicines that are currently sold over-the-counter.  In contrast, 29% of voters supported the new law.
  • By a 59%-35% spread, voters were more likely to agree "it is not worth inconveniencing, or possibly criminalizing law-abiding Hoosiers who benefit from over-the-counter cold or allergy medicines" than that "the benefits would outweigh the inconvenience or cost of a new law."
  • A 65%-majority were "less supportive" toward changing the law knowing that it could increase costs to taxpayers, as uninsured Hoosiers would have to visit emergency rooms to get prescriptions for these medicines.

CHPA is the 132-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa-info.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sonitus Medical Announces Affirmative Update Regarding Bone Conduction Oral Appliances in American Academy of Otolaryngology-Head and Neck Surgery Policy Statement on Implantable Hearing Devices
2. Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients
3. Statement from Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on the Front Page New York Times Story Regarding the Pre-emptive Strikes of Amgen/Genentech to Restrict Access to Affordable and Safe Biosimilars
4. Emmaus Life Sciences Issues Statement in Response to Announcement by AFH Holding & Advisory
5. Hill-Rom Reports Fiscal First Quarter Results; Updates 2013 Financial Outlook For R&D Tax Credit Reinstatement
6. CVS Caremark Statement and Response to CMS Action
7. World Renowned Scientist, Dr. Rongxiang Xu Speaks Out About Nobel Assembly Statement Claiming They Have Not Heard Of Him
8. STATEMENT OF CHAIRMAN AND CEO GEORGE BARRETT FORTUNE 21 CARDINAL HEALTH REGARDING FISCAL CLIFF
9. PCMA Statement on Essential Health Benefits Proposed Rule
10. Emmaus CEO Yutaka Niihara, M.D., Issues Statement In Connection with Status of Companys Phase III FDA Sickle Cell Treatment Trials
11. Academy of Managed Care Pharmacy (AMCP) Statement on Outcome of 2012 Presidential Election
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... IRVING, Texas , Oct. 11, 2017  Caris ... science focused on fulfilling the promise of precision medicine, ... Institute has joined Caris, Precision Oncology Alliance™ (POA) as ... leading cancer centers, the St. Jude Crosson Cancer Institute ... to advance the use of tumor profiling, making cancer ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
Breaking Medicine News(10 mins):